{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetAnalysis",
 "url": "https://clearank.com/stock/tmo-stock-analysis/",
 "dataUrl": "https://clearank.com/stock/tmo-stock-analysis/data.json",
 "title": "Thermo Fisher (TMO) Stock Forecast & Price Target (2026)",
 "description": "Thermo Fisher Scientific Inc. (TMO) stock: Healthcare, Diagnostics & Research. $223.0B market cap. AI rating, technicals, 2030 forecast and trade plans.",
 "headline": "Thermo Fisher Scientific Inc. (TMO)",
 "published": "2026-07-10T09:39:39+00:00",
 "modified": "2026-09-11T14:48:30.141+00:00",
 "generated": "2026-09-11T20:41:03.189Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "asset": {
  "ticker": "TMO",
  "name": "Thermo Fisher Scientific Inc.",
  "type": "Common Stock",
  "exchange": "NYSE",
  "currency": "USD",
  "sector": "Healthcare",
  "industry": "Diagnostics & Research",
  "country": "United States",
  "website": "https://www.thermofisher.com"
 },
 "quote": {
  "price": 607.5,
  "previousClose": 603.18,
  "change": 4.32,
  "changePercent": 0.72,
  "open": 609.355,
  "high": 610.915,
  "low": 606.26,
  "volume": 23083,
  "averageVolume": 1470808,
  "marketCap": 223024164272,
  "fiftyTwoWeekHigh": 647,
  "fiftyTwoWeekLow": 435.26999,
  "marketOpen": false,
  "asOf": "2026-09-11T14:48:29.000Z"
 },
 "statistics": {
  "pe": 32.63328,
  "eps": 18.57,
  "dividendYield": 0.003094650205761317,
  "beta": 0.854,
  "priceToSales": 4.835697,
  "priceToBook": 4.253437,
  "revenueTtm": 46336000000,
  "grossMargin": 0.40703685175921295,
  "returnOnEquity": 0.13515
 },
 "technicals": {
  "rsi": 36.84,
  "macd": 7.74,
  "sma50": 578.44,
  "sma200": 536.62,
  "rsiSignal": "Bearish",
  "trend": "Bullish",
  "pricePosition": "Bullish",
  "macdSignal": "Bullish",
  "rating": "Bullish"
 },
 "analysis": {
  "rating": "Buy",
  "score": 72,
  "consensus": "Buy",
  "fairValue": 650,
  "analystTarget": 650,
  "analystCount": 29,
  "wallStreetConsensus": "Buy",
  "generatedAt": "2026-09-11T14:48:29.000Z",
  "priceAtAnalysis": 607.5,
  "volatility": {
   "daily": 1.44,
   "risk": "standard"
  }
 },
 "tradePlan": {
  "bias": "Bullish",
  "conservativeEntry": 595.35,
  "aggressiveEntry": 607.5,
  "stopLoss": 577.49,
  "stopLossPercent": 3,
  "targets": [
   625.12,
   654.89,
   684.65
  ]
 },
 "projections": {
  "basis": "Monte Carlo simulation on historical return distribution, re-run daily; not price targets",
  "years": [
   {
    "year": 2027,
    "downside10th": 479.7,
    "base": 674.26,
    "upside90th": 947.74
   },
   {
    "year": 2028,
    "downside10th": 462.39,
    "base": 748.37,
    "upside90th": 1211.2
   },
   {
    "year": 2029,
    "downside10th": 460.58,
    "base": 830.61,
    "upside90th": 1497.94
   },
   {
    "year": 2030,
    "downside10th": 466.63,
    "base": 921.9,
    "upside90th": 1821.36
   },
   {
    "year": 2031,
    "downside10th": 477.91,
    "base": 1023.21,
    "upside90th": 2190.7
   },
   {
    "year": 2032,
    "downside10th": 493.26,
    "base": 1135.66,
    "upside90th": 2614.71
   },
   {
    "year": 2033,
    "downside10th": 512.08,
    "base": 1260.47,
    "upside90th": 3102.6
   },
   {
    "year": 2034,
    "downside10th": 534.09,
    "base": 1399,
    "upside90th": 3664.54
   },
   {
    "year": 2035,
    "downside10th": 559.15,
    "base": 1552.75,
    "upside90th": 4311.93
   },
   {
    "year": 2036,
    "downside10th": 587.25,
    "base": 1723.4,
    "upside90th": 5057.66
   }
  ]
 },
 "faqCount": 7,
 "sources": [
  "TwelveData",
  "Wall Street consensus"
 ],
 "sections": [
  {
   "id": "price",
   "title": "TMO Price Analysis"
  },
  {
   "id": "market-metrics",
   "title": "Market Metrics",
   "facts": {
    "Open": "$609.36",
    "Day Range": "$606.26 to $610.92",
    "Prev Close": "$603.18",
    "Volume": "23.1K",
    "52-Week Range": "$435.27 to $647.00",
    "Market Cap": "$223.02B"
   }
  },
  {
   "id": "peer-benchmarking",
   "title": "Peer Benchmarking",
   "text": [
    "Sector Position Analysis Valuation is broadly in line with sector peers (2% difference), suggesting fair market pricing relative to industry standards."
   ]
  },
  {
   "id": "financials",
   "title": "TMO Financial Performance",
   "text": [
    "Analysis: In the last 5 quarters, TMO beat estimates 5 times. However, the stock fell 3 times the next day. This suggests positive news is often \"priced in\" or investors are selling the news."
   ]
  },
  {
   "id": "analysis",
   "title": "TMO Analysis",
   "text": [
    "Thermo Fisher Scientific Inc. (TMO) is trading above its 50-day and 200-day moving averages ($578.44 and $536.62), signaling an overall bullish trend. The RSI is at 36.84, indicating bearish momentum, suggesting a potential for a pullback or consolidation. MACD is positive at 7.74, supporting the current upward trend. Key support levels are implied by the moving averages, with the 50-day SMA at $578.44 and the 200-day SMA at $536.62. Volume remains significantly below average, suggesting a lack of strong conviction behind recent price action.",
    "Thermo Fisher Scientific Inc. (TMO) has a track record of exceeding analyst EPS estimates, most recently by 5.6% in Q3 2026, which supports ongoing investor confidence.",
    "The company's revenue growth of 10.5% surpasses the sector average, indicating effective market penetration and demand for its diagnostics and research products.",
    "Insiders have sold a substantial $172.4 million worth of TMO stock, indicating potential concerns or profit-taking at current valuation levels.",
    "The current RSI of 36.84 suggests weakening momentum and a potential for a short-term price correction.",
    "Thermo Fisher Scientific Inc. (TMO) is expected to see continued growth, with analysts projecting revenue of approximately $47.9 billion for the current year, representing a 7.00% increase year-over-year. The median price target of $650.00 suggests a modest 7% upside from current levels, reflecting a base case scenario where the company maintains its market leadership and consistent earnings performance. The company's strong revenue growth, outpacing sector averages, supports this outlook."
   ],
   "lists": {
    "ProTips": [
     "Monitor insider selling activity closely, as the recent $172.4 million in dispositions could signal a shift in management's short-term confidence.",
     "The stock's RSI is in bearish territory, suggesting that a pullback or consolidation phase may be imminent, despite trading above key moving averages.",
     "Consider position sizing carefully given the significant insider selling and the relatively modest analyst upside potential."
    ]
   },
   "catalysts": [
    {
     "type": "Bullish",
     "title": "Consistent Earnings Beats",
     "text": "Thermo Fisher Scientific Inc. (TMO) has a track record of exceeding analyst EPS estimates, most recently by 5.6% in Q3 2026, which supports ongoing investor confidence.",
     "source": "Earnings Reports"
    },
    {
     "type": "Bullish",
     "title": "Strong Revenue Growth",
     "text": "The company's revenue growth of 10.5% surpasses the sector average, indicating effective market penetration and demand for its diagnostics and research products.",
     "source": "Company Filings"
    },
    {
     "type": "Bearish",
     "title": "Heavy Insider Selling Signal",
     "text": "Insiders have sold a substantial $172.4 million worth of TMO stock, indicating potential concerns or profit-taking at current valuation levels.",
     "source": "Insider Transactions"
    },
    {
     "type": "Bearish",
     "title": "Bearish RSI Momentum",
     "text": "The current RSI of 36.84 suggests weakening momentum and a potential for a short-term price correction.",
     "source": "Technical Analysis"
    }
   ]
  },
  {
   "id": "key-statistics",
   "title": "Key Statistics",
   "text": [
    "Thermo Fisher Scientific Inc. (TMO) exhibits a P/E ratio of 32.63, which is slightly above the sector median of 31.9, indicating a modest premium valuation. The company's revenue growth of 10.5% outpaces the sector average of 8.1%, suggesting strong market positioning. The consistent earnings beats and positive revenue trajectory support the current valuation. The dividend yield is approximately 0.30%, offering a small income component.",
    "Thermo Fisher Scientific Inc. (TMO) has demonstrated a pattern of exceeding analyst earnings expectations. The most recent quarter, ending July 23, 2026, saw EPS of $6.03 against an estimate of $5.71, a 5.6% surprise, though the stock saw a minor decline of 0.71%. Prior quarters also showed positive surprises, including a significant 30.35% beat in March 2026. Revenue growth has been strong, with current year estimates projecting 7.00% year-over-year growth.",
    "Significant insider selling, totaling $172.4 million, presents a notable risk, contrasting with the generally positive analyst sentiment. While the stock is trading above key moving averages, the bearish RSI momentum suggests potential for a near-term pullback. Competition within the Diagnostics & Research industry remains intense, requiring continuous innovation and market share defense."
   ],
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "Market Cap",
       "cells": [
        "223.02B"
       ]
      },
      {
       "label": "P/E Ratio",
       "cells": [
        "32.63"
       ]
      },
      {
       "label": "EPS (TTM)",
       "cells": [
        "18.57"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "0.2963%"
       ]
      },
      {
       "label": "52 Week High",
       "cells": [
        "647.00"
       ]
      },
      {
       "label": "52 Week Low",
       "cells": [
        "435.27"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "technical-indicators",
   "title": "Technical Indicators",
   "text": [
    "Technical Rating Bullish RSI Bearish SMA Cross Bullish Price vs SMA Bullish MACD Bullish Golden Cross in effect with the 50-day SMA ($578.44) above the 200-day SMA ($536.62), price action is firmly bullish above key moving averages."
   ],
   "facts": {
    "RSI": "Bearish",
    "SMA Cross": "Bullish",
    "Price vs SMA": "Bullish",
    "MACD": "Bullish"
   },
   "tables": [
    {
     "caption": "",
     "columns": [],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "36.84"
       ]
      },
      {
       "label": "MACD",
       "cells": [
        "7.74"
       ]
      },
      {
       "label": "SMA 50",
       "cells": [
        "578.44"
       ]
      },
      {
       "label": "SMA 200",
       "cells": [
        "536.62"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "correlations",
   "title": "Market Correlations",
   "text": [
    "How this stock moves relative to other assets",
    "Based on 1 year of daily price data. Correlations may vary over different time periods."
   ],
   "facts": {
    "Correlation with S&P 500 (SPY)": "+0.41",
    "Correlation with Nasdaq 100 (QQQ)": "+0.29",
    "Correlation with Bitcoin (BTC)": "+0.20",
    "Correlation with Gold (XAU)": "+0.05"
   }
  },
  {
   "id": "trade-plans",
   "title": "TMO Trade Plans",
   "text": [
    "Specific entry, exit, and risk management levels",
    "Lower risk, wait for pullback",
    "Higher risk, immediate entry",
    "Volatility-Adjusted Stop Loss Calculated based on RSI (36.8) and current market volatility",
    "Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3"
   ],
   "facts": {
    "TARGET 1": "$625.12",
    "TARGET 2": "$654.89",
    "TARGET 3": "$684.65",
    "STOP LOSS": "$577.49"
   }
  },
  {
   "id": "seasonality",
   "title": "Seasonal Patterns",
   "text": [
    "Historical monthly performance trends",
    "Based on 3 years of historical monthly returns"
   ],
   "facts": {
    "Average Jan return": "+4.25%",
    "Average Feb return": "-5.21%",
    "Average Mar return": "+0.10%",
    "Average Apr return": "+1.05%",
    "Average May return": "+0.19%",
    "Average Jun return": "+2.38%",
    "Average Jul return": "+7.94%",
    "Average Aug return": "+2.20%",
    "Average Sep return": "+0.11%",
    "Average Oct return": "-0.48%",
    "Average Nov return": "+2.20%",
    "Average Dec return": "-0.04%"
   }
  },
  {
   "id": "risk",
   "title": "Risk & Volatility",
   "facts": {
    "Daily Volatility": "1.44%"
   },
   "lists": {
    "Risk considerations": [
     "Monitor position sizing based on current volatility levels",
     "Consider stop-loss placement beyond recent price range",
     "Diversification helps mitigate single-stock risk exposure"
    ]
   }
  },
  {
   "id": "growth",
   "title": "Growth of $10,000",
   "text": [
    "A $10,000 investment in TMO in September 2016 would be worth about $41,201 today, compared with about $35,030 for the same investment in the S&P 500 benchmark."
   ]
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)",
   "text": [
    "CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in TMO today could grow to about $28,369 by 2036 in the base case, with a bull case near $83,254 and a bear case around $9,667. Projections are statistical simulations, not guarantees."
   ]
  },
  {
   "id": "price-prediction",
   "title": "TMO Stock Price Prediction: 2030",
   "text": [
    "CleaRank's simulation projects a price near $922 for TMO by 2030 in the base case, from $608 today (1.5x over 4 years). The downside path ends near $467. These are outcomes of a Monte Carlo simulation run on TMO's historical return distribution, not price targets, and they assume no dividends are reinvested.",
    "Method: 10,000 simulated price paths using TMO's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice."
   ],
   "tables": [
    {
     "caption": "TMO simulated price paths by year",
     "columns": [
      "Year",
      "Downside (10th pct)",
      "Base case",
      "Upside (90th pct)"
     ],
     "rows": [
      {
       "label": "2027",
       "cells": [
        "$480",
        "$674",
        "$948"
       ]
      },
      {
       "label": "2028",
       "cells": [
        "$462",
        "$748",
        "$1,211"
       ]
      },
      {
       "label": "2029",
       "cells": [
        "$461",
        "$831",
        "$1,498"
       ]
      },
      {
       "label": "2030",
       "cells": [
        "$467",
        "$922",
        "$1,821"
       ]
      },
      {
       "label": "2031",
       "cells": [
        "$478",
        "$1,023",
        "$2,191"
       ]
      },
      {
       "label": "2032",
       "cells": [
        "$493",
        "$1,136",
        "$2,615"
       ]
      },
      {
       "label": "2033",
       "cells": [
        "$512",
        "$1,260",
        "$3,103"
       ]
      },
      {
       "label": "2034",
       "cells": [
        "$534",
        "$1,399",
        "$3,665"
       ]
      },
      {
       "label": "2035",
       "cells": [
        "$559",
        "$1,553",
        "$4,312"
       ]
      },
      {
       "label": "2036",
       "cells": [
        "$587",
        "$1,723",
        "$5,058"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "IQV IQVIA Holdings Inc. NYSE $257.30 +0.1245%",
     "url": "https://clearank.com/stock/iqvia-iqv/"
    },
    {
     "text": "CI The Cigna Group NYSE $278.36 -0.9095%",
     "url": "https://clearank.com/stock/cigna-group-ci/"
    },
    {
     "text": "DHR Danaher Corp. NYSE $200.53 -2.11%",
     "url": "https://clearank.com/stock/dhr-stock-analysis/"
    },
    {
     "text": "MCK McKesson Corporation NYSE $880.86 -1.21%",
     "url": "https://clearank.com/stock/mck-stock-analysis/"
    },
    {
     "text": "HUM Humana Inc. NYSE $403.51 +0.8725%",
     "url": "https://clearank.com/stock/hum-stock-analysis/"
    },
    {
     "text": "LLY Eli Lilly and Company NYSE $1,122.31 -0.0619%",
     "url": "https://clearank.com/stock/eli-lilly-lly/"
    },
    {
     "text": "TEM Tempus AI Inc NASDAQ $58.74 -4.14%",
     "url": "https://clearank.com/stock/tempus-ai-tem/"
    },
    {
     "text": "BDX Becton, Dickinson and Company NYSE $176.42 -1.88%",
     "url": "https://clearank.com/stock/bdx-stock-analysis/"
    }
   ]
  },
  {
   "id": "related-comparisons",
   "title": "Popular Comparisons",
   "links": [
    {
     "text": "VOO vs VTI Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/voo-vs-vti/"
    },
    {
     "text": "VUG vs VOOG Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/vug-vs-voog/"
    },
    {
     "text": "MSTR vs COIN Comparison Head-to-head analysis →",
     "url": "https://clearank.com/compare/mstr-vs-coin/"
    }
   ]
  },
  {
   "id": "insider-trading",
   "title": "TMO Insider Trading Analysis",
   "facts": {
    "Bought": "None",
    "Sold": "$172.4M",
    "Insiders": "20",
    "Avg Transaction": "$5.1M"
   },
   "tables": [
    {
     "caption": "Recent insider transactions in TMO",
     "columns": [
      "Date",
      "Insider",
      "Type",
      "Shares",
      "Value"
     ],
     "rows": [
      {
       "label": "Dec 3, 2025",
       "cells": [
        "LAGARDE MICHEL Chief Operating Officer",
        "Sell",
        "62.0K",
        "$36.1M"
       ]
      },
      {
       "label": "Nov 2, 2021",
       "cells": [
        "STEVENSON MARK P Chief Operating Officer",
        "Sell",
        "53.9K",
        "$34.2M"
       ]
      },
      {
       "label": "Oct 1, 2018",
       "cells": [
        "CASPER MARC N Chief Executive Officer",
        "Sell",
        "125.5K",
        "$31.1M"
       ]
      },
      {
       "label": "May 10, 2021",
       "cells": [
        "LAGARDE MICHEL Officer",
        "Sell",
        "55.8K",
        "$26.2M"
       ]
      },
      {
       "label": "Feb 10, 2023",
       "cells": [
        "CASPER MARC N Chief Executive Officer",
        "Sell",
        "40.0K",
        "$22.9M"
       ]
      },
      {
       "label": "Dec 1, 2021",
       "cells": [
        "STEVENSON MARK P Chief Operating Officer",
        "Sell",
        "26.9K",
        "$17.0M"
       ]
      },
      {
       "label": "Jul 29, 2020",
       "cells": [
        "CASPER MARC N Chief Executive Officer",
        "Sell",
        "40.0K",
        "$16.5M"
       ]
      },
      {
       "label": "Aug 15, 2022",
       "cells": [
        "WILLIAMSON STEPHEN Chief Financial Officer",
        "Sell",
        "27.3K",
        "$16.4M"
       ]
      },
      {
       "label": "May 27, 2022",
       "cells": [
        "LAGARDE MICHEL Chief Operating Officer",
        "Sell",
        "29.8K",
        "$16.3M"
       ]
      },
      {
       "label": "Jul 31, 2020",
       "cells": [
        "CASPER MARC N Chief Executive Officer",
        "Sell",
        "40.0K",
        "$16.3M"
       ]
      }
     ]
    }
   ],
   "links": [
    {
     "text": "SEC Form 4",
     "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=Thermo+Fisher+Scientific+Inc.&type=4&dateb=&owner=include&count=40&search_text=&action=getcompany"
    }
   ]
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  }
 ],
 "faq": [
  {
   "question": "Is Thermo Fisher Scientific Inc. stock a buy?",
   "answer": "Thermo Fisher Scientific Inc. (TMO) is currently rated a 'Buy' by Wall Street analysts, with a median price target of $650.00, indicating a 7% upside potential from its current price of $607.50. The company consistently beats earnings estimates and shows strong revenue growth."
  },
  {
   "question": "What is Thermo Fisher Scientific Inc.'s stock price forecast for 2030?",
   "answer": "Based on Monte Carlo simulations, Thermo Fisher Scientific Inc.'s (TMO) stock price is projected to be around $921.90 by 2030 in a base case scenario, with a downside projection of $466.63 and an upside projection of $1821.36."
  },
  {
   "question": "What are the main risks for Thermo Fisher Scientific Inc. stock?",
   "answer": "The primary risks for Thermo Fisher Scientific Inc. (TMO) include significant insider selling totaling $172.4 million and bearish momentum indicated by its RSI. Intense competition within the healthcare diagnostics sector also poses a challenge."
  },
  {
   "question": "How has Thermo Fisher Scientific Inc. performed in recent earnings reports?",
   "answer": "Thermo Fisher Scientific Inc. (TMO) has a history of beating earnings estimates, with the latest quarter showing a 5.6% EPS surprise. Revenue growth remains strong, projected at 7.00% for the current year."
  },
  {
   "question": "What is Thermo Fisher Scientific Inc.'s valuation compared to its sector?",
   "answer": "Thermo Fisher Scientific Inc. (TMO) trades at a P/E ratio of 32.63, which is slightly higher than the sector median of 31.9. However, its revenue growth of 10.5% exceeds the sector average of 8.1%."
  },
  {
   "question": "What is the analyst consensus for Thermo Fisher Scientific Inc. stock?",
   "answer": "The analyst consensus for Thermo Fisher Scientific Inc. (TMO) is 'Buy', supported by a Wall Street score of 72 out of 100. There are 4 'Strong Buy' ratings, 19 'Buy' ratings, and 5 'Hold' ratings among 29 analysts."
  },
  {
   "question": "What is the current technical outlook for Thermo Fisher Scientific Inc. stock?",
   "answer": "Thermo Fisher Scientific Inc. (TMO) is trading above its 50-day and 200-day moving averages ($578.44 and $536.62), indicating a generally positive trend. However, its RSI is in bearish territory, suggesting potential for a short-term pullback."
  }
 ],
 "related": {
  "peopleAlsoWatch": [
   {
    "ticker": "IQV",
    "name": "IQVIA Holdings Inc. NYSE",
    "price": "$257.30",
    "change": "+0.1245%",
    "url": "https://clearank.com/stock/iqvia-iqv/"
   },
   {
    "ticker": "CI",
    "name": "The Cigna Group NYSE",
    "price": "$278.36",
    "change": "-0.9095%",
    "url": "https://clearank.com/stock/cigna-group-ci/"
   },
   {
    "ticker": "DHR",
    "name": "Danaher Corp. NYSE",
    "price": "$200.53",
    "change": "-2.11%",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "MCK",
    "name": "McKesson Corporation NYSE",
    "price": "$880.86",
    "change": "-1.21%",
    "url": "https://clearank.com/stock/mck-stock-analysis/"
   },
   {
    "ticker": "HUM",
    "name": "Humana Inc. NYSE",
    "price": "$403.51",
    "change": "+0.8725%",
    "url": "https://clearank.com/stock/hum-stock-analysis/"
   },
   {
    "ticker": "LLY",
    "name": "Eli Lilly and Company NYSE",
    "price": "$1,122.31",
    "change": "-0.0619%",
    "url": "https://clearank.com/stock/eli-lilly-lly/"
   },
   {
    "ticker": "TEM",
    "name": "Tempus AI Inc NASDAQ",
    "price": "$58.74",
    "change": "-4.14%",
    "url": "https://clearank.com/stock/tempus-ai-tem/"
   },
   {
    "ticker": "BDX",
    "name": "Becton, Dickinson and Company NYSE",
    "price": "$176.42",
    "change": "-1.88%",
    "url": "https://clearank.com/stock/bdx-stock-analysis/"
   }
  ],
  "comparisons": [
   {
    "ticker": "VOO vs VTI Comparison",
    "name": "",
    "url": "https://clearank.com/compare/voo-vs-vti/"
   },
   {
    "ticker": "VUG vs VOOG Comparison",
    "name": "",
    "url": "https://clearank.com/compare/vug-vs-voog/"
   },
   {
    "ticker": "MSTR vs COIN Comparison",
    "name": "",
    "url": "https://clearank.com/compare/mstr-vs-coin/"
   }
  ],
  "sectorHub": {
   "text": "Browse all Healthcare →",
   "url": "https://clearank.com/sector/healthcare/"
  },
  "Newly Tracked": [
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "VRSK",
    "text": "Verisk Analytics, Inc.",
    "url": "https://clearank.com/stock/vrsk-stock-analysis/"
   },
   {
    "ticker": "DEO",
    "text": "Diageo plc Sponsored",
    "url": "https://clearank.com/stock/deo-stock-analysis/"
   },
   {
    "ticker": "KMB",
    "text": "Kimberly-Clark Corporation",
    "url": "https://clearank.com/stock/kmb-stock-analysis/"
   },
   {
    "ticker": "IAUM",
    "text": "iShares Gold Trust Micro",
    "url": "https://clearank.com/etf/iaum-etf-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "NEAR/USD",
    "text": "↑ 18.46%",
    "url": "https://clearank.com/crypto/near-protocol-near-usd/"
   },
   {
    "ticker": "THETA/USD",
    "text": "↑ 15.25%",
    "url": "https://clearank.com/crypto/theta-network-theta-usd/"
   },
   {
    "ticker": "HPE",
    "text": "↑ 10.41%",
    "url": "https://clearank.com/stock/hewlett-packard-enterprise-hpe/"
   },
   {
    "ticker": "DELL",
    "text": "↑ 10.23%",
    "url": "https://clearank.com/stock/dell-technologies-dell/"
   },
   {
    "ticker": "IMSR",
    "text": "↓ 9.79%",
    "url": "https://clearank.com/stock/terrestrial-energy-imsr/"
   }
  ],
  "Also in Healthcare": [
   {
    "ticker": "DHR",
    "text": "Danaher",
    "url": "https://clearank.com/stock/dhr-stock-analysis/"
   },
   {
    "ticker": "IDXX",
    "text": "IDEXX",
    "url": "https://clearank.com/stock/idxx-stock-analysis/"
   },
   {
    "ticker": "ILMN",
    "text": "Illumina Inc.",
    "url": "https://clearank.com/stock/ilmn-stock-analysis/"
   },
   {
    "ticker": "IQV",
    "text": "IQVIA Holdings Inc.",
    "url": "https://clearank.com/stock/iqvia-iqv/"
   },
   {
    "ticker": "NTRA",
    "text": "Natera, Inc.",
    "url": "https://clearank.com/stock/natera-ntra/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "url": "https://clearank.com",
     "sameAs": [
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "email": "info@clearank.com",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "description": "The CleaRank vision is to bring clarity to the online trading industry and protect trader interests. We use our proprietary technology, expert analysis and verified trader insights, to deliver data driven broker evaluations you can trust. Our CLEAR™ Score is our foundation, a transparent, unbiased methodology that assesses brokers and firms based on the most critical factors including regulation, fees, platform reliability, and real user experiences. We are here to change an unfair system and unlike other review sites that are influenced by partnerships or subjective opinions, CleaRank is 100% independent–abiding by our rigorous CLEAR™ editorial code. We do not accept financial incentives from brokers, so what you see is what you get with no hidden agendas, just honest, actionable feedback. Clear data. Honest reviews. That's the CleaRank promise",
     "numberOfEmployees": {
      "@type": "QuantitativeValue",
      "value": "40"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/07/TMO-thermo-fisher-scientific-analysis-2026-07.png",
     "url": "https://clearank.com/wp-content/uploads/2026/07/TMO-thermo-fisher-scientific-analysis-2026-07.png",
     "width": "1280",
     "height": "720",
     "caption": "Thermo Fisher Scientific (TMO) stock price analysis chart for July 2026",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/stock/tmo-stock-analysis/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/stock/tmo-stock-analysis/",
        "name": "Thermo Fisher (TMO) Stock Analysis"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/stock/tmo-stock-analysis/#webpage",
     "url": "https://clearank.com/stock/tmo-stock-analysis/",
     "name": "Thermo Fisher (TMO) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-10T09:39:39+00:00",
     "dateModified": "2026-09-11T14:48:30+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/TMO-thermo-fisher-scientific-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/stock/tmo-stock-analysis/#breadcrumb"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/writer/clearank/",
     "name": "CleaRank",
     "description": "CleaRank's vision is to bring clarity to the online trading industry and protecting trader interests by delivering data-driven broker evaluations you can trust.",
     "url": "https://clearank.com/writer/clearank/",
     "image": {
      "@type": "ImageObject",
      "@id": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "url": "https://secure.gravatar.com/avatar/4900cf75f960a22a21f1c864e98abc4d5285fa159ea1025d0e8a9db5136e28ef?s=96&d=mm&r=g",
      "caption": "CleaRank",
      "inLanguage": "en-US"
     },
     "sameAs": [
      "https://clearank.com/",
      "https://twitter.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     },
     "logo": "https://clearank.com/wp-content/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg"
    },
    {
     "@type": "Article",
     "headline": "Thermo Fisher (TMO) Stock Forecast & Price Target (2026)",
     "datePublished": "2026-07-10T09:39:39+00:00",
     "dateModified": "2026-09-11T14:48:30+00:00",
     "author": {
      "@id": "https://clearank.com/writer/clearank/",
      "name": "CleaRank"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "description": "Thermo Fisher Scientific Inc. (TMO) stock: Healthcare, Diagnostics & Research. $223.0B market cap. AI rating, technicals, 2030 forecast and trade plans.",
     "name": "Thermo Fisher (TMO) Stock Forecast & Price Target (2026)",
     "@id": "https://clearank.com/stock/tmo-stock-analysis/#richSnippet",
     "isPartOf": {
      "@id": "https://clearank.com/stock/tmo-stock-analysis/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/07/TMO-thermo-fisher-scientific-analysis-2026-07.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/stock/tmo-stock-analysis/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FinancialProduct",
   "name": "Thermo Fisher Scientific Inc. (TMO)",
   "tickerSymbol": "TMO",
   "url": "https://clearank.com/stock/tmo-stock-analysis/",
   "description": "AI-powered financial analysis for Thermo Fisher Scientific Inc. (TMO) including technical indicators, market metrics, valuation, and price targets - refreshed daily by CleaRank Financial AI.",
   "exchange": "NYSE",
   "offers": {
    "@type": "Offer",
    "price": 607.5,
    "priceCurrency": "USD",
    "availability": "https://schema.org/InStock",
    "url": "https://clearank.com/stock/tmo-stock-analysis/",
    "priceValidUntil": "2026-09-12"
   }
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Is Thermo Fisher Scientific Inc. stock a buy?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Thermo Fisher Scientific Inc. (TMO) is currently rated a 'Buy' by Wall Street analysts, with a median price target of $650.00, indicating a 7% upside potential from its current price of $607.50. The company consistently beats earnings estimates and shows strong revenue growth."
     }
    },
    {
     "@type": "Question",
     "name": "What is Thermo Fisher Scientific Inc.'s stock price forecast for 2030?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Based on Monte Carlo simulations, Thermo Fisher Scientific Inc.'s (TMO) stock price is projected to be around $921.90 by 2030 in a base case scenario, with a downside projection of $466.63 and an upside projection of $1821.36."
     }
    },
    {
     "@type": "Question",
     "name": "What are the main risks for Thermo Fisher Scientific Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The primary risks for Thermo Fisher Scientific Inc. (TMO) include significant insider selling totaling $172.4 million and bearish momentum indicated by its RSI. Intense competition within the healthcare diagnostics sector also poses a challenge."
     }
    },
    {
     "@type": "Question",
     "name": "How has Thermo Fisher Scientific Inc. performed in recent earnings reports?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Thermo Fisher Scientific Inc. (TMO) has a history of beating earnings estimates, with the latest quarter showing a 5.6% EPS surprise. Revenue growth remains strong, projected at 7.00% for the current year."
     }
    },
    {
     "@type": "Question",
     "name": "What is Thermo Fisher Scientific Inc.'s valuation compared to its sector?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Thermo Fisher Scientific Inc. (TMO) trades at a P/E ratio of 32.63, which is slightly higher than the sector median of 31.9. However, its revenue growth of 10.5% exceeds the sector average of 8.1%."
     }
    },
    {
     "@type": "Question",
     "name": "What is the analyst consensus for Thermo Fisher Scientific Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "The analyst consensus for Thermo Fisher Scientific Inc. (TMO) is 'Buy', supported by a Wall Street score of 72 out of 100. There are 4 'Strong Buy' ratings, 19 'Buy' ratings, and 5 'Hold' ratings among 29 analysts."
     }
    },
    {
     "@type": "Question",
     "name": "What is the current technical outlook for Thermo Fisher Scientific Inc. stock?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Thermo Fisher Scientific Inc. (TMO) is trading above its 50-day and 200-day SMAs, indicating a generally positive trend. However, its RSI is in bearish territory, suggesting potential for a short-term pullback."
     }
    }
   ]
  }
 ]
}